Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis

Clinical and Experimental Immunology

Volumn 171, Issue 3, 2013, Pages 330-337

  Sano, Y ^a   Masuda, K ^a   Tamagawa Mineoka, R ^a   Matsunaka, H ^b   Murakami, Y ^b   Yamashita, R ^b   Morita, E ^c   Katoh, N ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Research and Development   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

Atopy; CD4 T cells (Th2); Skin immunology disease

Indexed keywords

BIOLOGICAL MARKER; DERMATOLOGICAL AGENT; SKIN MOISTURIZER; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL SKIN REACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EPIDERMIS; ERYTHEMA; EXCORIATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LICHENOID ERUPTION; MALE; PAPULE; PRIORITY JOURNAL; SCORING SYSTEM; SEVERITY SCORING OF ATOPIC DERMATITIS; SKIN EDEMA; SKIN WATER LOSS; STRATUM CORNEUM; XEROSIS;

ADULT; BIOLOGICAL MARKERS; BODY WATER; CYTOKINES; DERMATITIS, ATOPIC; FEMALE; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84873304655     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12021     Document Type: Article

References (29)

1. Bieber T. Atopic dermatitis. Ann Dermatol 2010; 22:125-134.
2. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101:1614-1622.
3. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998; 28:769-779.
4. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 2007; 120:238-244.
5. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269-273.
6. Soumelis V, Reche PA, Kanzler H etal. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3:673-680.
7. Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a Th2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol 2010; 126:976-984.
8. Angelova-Fischer I, Fernandez IM, Donnadieu MH etal. Injury to stratum corneum induces in vivo expression of human thymic stromal lymphopoietin. J Invest Dermatol 2010; 130:2505-2507.
9. Morita E, Takahashi H, Niihara H etal. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy 2010; 65:1166-1172.
10. Inoue Y, Aihara M, Kirino M etal. Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with Staphylococcus aureus colonization. Br J Dermatol 2011; 164:560-567.
11. Furue M, Saeki H, Furukawa F etal. Guidelines for management of atopic dermatitis. J Dermatol 2009; 36:563-577.
12. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195:10-19.
13. Li M, Messaddeq N, Teletin M, Pasquali JL, Metzger D, Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci USA 2005; 102:14795-14800.
14. Yoo J, Omori M, Gyarmati D etal. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005; 202:541-549.
15. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006; 103:11736-11741.
16. Nakamura K, Tsuchida T, Tsunemi Y, Saeki H, Tamaki K. Serum thymic stromal lymphopoietin levels are not elevated in patients with atopic dermatitis. J Dermatol 2008; 35:546-547.
17. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012; 122:440-447.
18. Demehri S, Liu Z, Lee J etal. Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol 2008; 6:e123.
19. Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts. J Allergy Clin Immunol 2011; 127:1110-1118.
20. Cork MJ, Danby SG, Vasilopoulos Y etal. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129:1892-1908.
21. Vasilopoulos Y, Cork MJ, Murphy R etal. Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123:62-66.
22. Hansson L, Bäckman A, Ny A etal. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 2002; 118:444-449.
23. Walley AJ, Chavanas S, Moffatt MF etal. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001; 29:175-178.
24. Kusunoki T, Okafuji I, Yoshioka T etal. SPINK5 polymorphism is associated with disease severity and food allergy in children with atopic dermatitis. J Allergy Clin Immunol 2005; 115:486-492.
25. Hachem JP, Houben E, Crumrine D etal. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006; 126:2074-2086.
26. Briot A Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 2010; 130:2736-2742.
27. Jensen JM, Fölster-Holst R, Baranowsky A etal. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122:1423-1431.
28. Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol 2010; 63:587-593.
29. Steinhoff M, Neisius U, Ikoma A etal. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23:6176-6180.